Plus   Neg

Airbus Slips To Loss In H1 - Quick Facts

European plane maker Airbus (EADSF.PK,EADSY.PK) reported that its net loss for the first-half of 2020 was 1.92 billion euros compared to net income of 1.20 billion euros in the previous year. Loss per share was 2.45 euros, compared to earnings per share of 1.54 euros in the prior year. The financial result reflected a negative 212 million euros related to Dassault Aviation as well as the impairment of a loan toOneWeb, recorded in first-quarter 2020 for an amount of negative 136 million euros.

Consolidated revenues for the period decreased to 18.9 billion euros from last year's 30.9 billion euros, hurt by the difficult market environment impacting the commercial aircraft business with around 50% fewer deliveries year-on-year. This was partly offset by more favourable foreign exchange rates.

The company's full-Year 2020 guidance was withdrawn in March. The impact of COVID-19 on the business continues to be assessed and given the limited visibility, in particular with respect to the delivery situation, no new guidance is issued, the company said.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Missouri City, Texas-based Adco Trading Inc. has recalled about 142,740 units of candles citing fire and burn risks, according to the U.S. Consumer Product Safety Commission. The recall involves Sure Scents 2-1 Peaceful Stream/Moonlit Waves Candles. The affected items were manufactured in United States and sold exclusively at Dollar Tree stores across the country from July 2020 through September 2 United Parcel Service imposed temporary shipping restrictions on some big retailers such as Nike, Macy's and Gap, due to the increased demand for online orders and delivery in this holiday season, media reports said quoting an email statement issued by the delivery giant. An advisory panel to the Centers for Disease Control and Prevention has proposed that healthcare workers and long-term facility residents be given the first doses of the COVID-19 vaccine when it is cleared for public use in the U.S. The CDC's Advisory Committee on Immunization Practices met virtually on Tuesday and panel passed the proposal 13-1.
Follow RTT